risk stratification Researchers ID Genomic Signature to Risk Stratify Patients With Precancerous Breast Lesions In the study, presented at SABCS, researchers developed an 812-gene signature that could identify which patients with ductal carcinoma in situ need aggressive treatment. Polygenic Risk Scores Edge Toward Clinic, Though Disease Prediction Utility Questions Linger Premium Researchers have conflicting interpretations of recent studies into how much polygenic risk scores might contribute to disease risk predictions. Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent The Australian company is working with the Institute for Public Health in St. Louis to expand the predictive capability of its GeneType breast cancer risk test. Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows The researchers said the approach could be a short-term measure while genetic studies of more diverse ancestral populations are performed. Oncocyte Launches Prospective Registry to Drive DetermaRx Adoption, Improve Coverage Premium Through its real-world evidence registry, the firm hopes to further validate its NSCLC recurrence risk test as a tool for guiding adjuvant treatment. Jul 28, 2021 Sequencing Firm Phosphorus Tests Limits of Comprehensive Consumer Genomics With GeneCompass Premium Jul 22, 2021 Volpara Adding Invitae Genetic Test Ordering to Breast Risk Software Platform Jul 15, 2021 Glaucoma Polygenic Risk Score Appears Similarly Informative to Monogenic Risk Assessment Jun 30, 2021 Recuro Health Enters Genomics Market With MyLegacy Purchase from Cleveland Clinic Premium Jun 7, 2021 Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion Premium Jan 26, 2021 BC Platforms, Finnish Researchers, Japan's Riken Partner on COVID-19 Risk Assessment Oct 26, 2020 GoodCell Raises $17.9M for Analytics Technology, Personal Biobanking Sep 9, 2020 Machine Learning Tool Enables Analysis of Complex, Polygenic Phenotypes With Epistastic Interactions Premium Aug 13, 2020 Weill Cornell Using $1.5M NIH Grant to Predict Severity of COVID-19 Cases Premium Jul 1, 2020 NIH Allocates $75M to Create eMERGE Risk Assessment Network Jun 18, 2020 After DNA-10K, NorthShore Looks to Expand Genomics Integration Into Primary Care Premium Jun 11, 2020 Diversity Problem Hinders Adoption of Polygenic Risk Scores, According to ESHG Panel May 13, 2020 The DNA Company Rebrands as My Next Health Following Acquisition May 7, 2020 Informatics Startup Breakthrough Genomics Developing Coronavirus Susceptibility Assessment Premium Apr 3, 2020 Adventist Health, CancerIQ Collaboration Identifying More Patients for Guidelines-Supported Genetic Testing Premium Jan 16, 2020 DNAFeed Adds Genetic Counseling to Scripps Polygenic Risk Study Premium Jun 7, 2019 Online Platform Helping Adventist Health Improve Breast Cancer Risk Assessment Premium Feb 13, 2019 IBM Watson, Broad Institute Expand Collaboration Into Heart Disease Oct 2, 2013 BioTheranostics Study Suggests BCI Test May Outperform Oncotype for Long-term Risk and HER2-neg Subset Premium Mar 13, 2013 Data Supports Oncotype DX for Predicting Recurrence in Node-Positive Cancers, Guiding Radiation Therapy Premium Load More Breaking News NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.